Meeting Posters

Patient Global Impression (PGI) and Clinician Global Impression (CGI) measures: Adoption patterns across CNS clinical research (Abstract)

Walsh
2026 Autumn Conference

Cognitive review of the Patient-Reported Depression Checklist: A patient-reported ePRO measure of symptom frequency and functional impact (Abstract)

Alphs
2026 Autumn Conference

Relationship between pharmacodynamic measures and efficacy in a clinical trial of a novel serotonergic agonist for generalized anxiety disorder (Abstract)

Kulikova
2026 Autumn Conference

Model-based detection of rater drift in CDR-SoB using centralized monitoring across two early Alzheimer’s disease trials (Abstract)

Kott
2026 Autumn Conference

Closed-loop machine learning for real-time engagement of children with disruptive behaviors (Abstract)

Croarkin
2026 Autumn Conference

Methodological implications for linking speech characteristics with measures of psychosis: A meta-analysis (Abstract)

Karazsia

EEG sample entropy and spectral power: Towards an applicable neuroimaging biomarker in psychedelic drug studies (Abstract)

Das
2026 Autumn Conference

Leveraging externally led Patient-Focused Drug Development (PFDD) meeting and survey data to enable patient-focused clinical trial design in schizophrenia (Abstract)

Frangiosa
2026 Autumn Conference

Toward precision mechanistic biomarkers of acamprosate response in alcohol use disorder: Methodology of a longitudinal EEG trial (Abstract)

Chholak
2026 Autumn Conference

Automated speaker verification for detecting identity anomalies and ensuring data integrity in multi-site CNS clinical trials (Abstract)

McVeigh
2026 Autumn Conference

A multi-source validation framework for smartphone-based walk tests (Abstract)

Abreu
2026 Autumn Conference

A Bayesian multimodal framework integrating digital biomarkers and clinician-rated measures for assessment of expressive negative symptoms in schizophrenia (Abstract)

Khan
2026 Autumn Conference

Schema-constrained, clinician-verified LLM abstraction to improve documentation completeness for CNS trial eligibility screening: A real-world methodology pilot (Abstract)

Padder
2026 Autumn Conference

Enrichment for canonical symptom presentation in generalized anxiety disorder (Abstract)

Wang
2026 Autumn Conference

Video vs audio-based PANSS independent review: A comparison of score discrepancy rates in 2 large acute schizophrenia clinical trials (Abstract)

Echevarria
2026 Autumn Conference

Toward wearable-driven individualized and context-specific behavior activation using major depression with sub-threshold symptoms as a test case (Abstract)

Marrero-Polanco
2026 Autumn Conference

Regulation of the kynurenine pathway metabolism with the galantamine-memantine combination in the treatment of HIV-associated neurocognitive disorder (Abstract)

Bhavsar
2026 Autumn Conference

Utility of patient experience data (PED) & patient preference data in patient focused drug development (PFDD) (Abstract)

Frangiosa
22nd Annual Scientific Meeting

Systematic review of patient focused drug development meeting reports for conditions affecting neurodevelopment (Abstract)

Farmer
22nd Annual Scientific Meeting

Speech pause and speech rate for evaluating Alzheimer’s and mild cognitive impairment: A meta-analysis (Abstract)

Cohen
22nd Annual Scientific Meeting